CXF-009
CXF-009 is a selective and covalent FGFR4 inhibitor, with the IC50 of 48 nM. CXF-009 targeting Cys477 and Cys552 of FGFR4, and can be used for the study of hepatocellular carcinoma[1].
Product Specifications
CAS Number
2727084-00-4
UNSPSC
12352005
Target
FGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cxf-009.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=C(NC2=NC=C3C(N(CCCN4CCN(CC4)C(C=C)=O)C(N(C3)C5=CC(OC)=CC(OC)=C5)=O)=N2)C=CC=C1)C=C
Molecular Formula
C33H38N8O5
Molecular Weight
626.71
References & Citations
[1]Chen X, et al. Structure-based design of a dual-warhead covalent inhibitor of FGFR4. Commun Chem. 2022;5 (1) :36. Published 2022 Mar 17.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881317-500 1x 500 µL
Thyroid Stimulating Hormone, beta (TSH beta) (Pituitary Marker) (TSHb/1317), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUM2152-50 1x 50 µL
TACSTD2 / TROP2 (Epithelial Marker) (TACSTD2/2152), 1mg/mL
Sign In for Pricing
View Details